M
MAIA Biotechnology D
D
MAIA
1.84000
USD
0.05
(2.79%)
مفتوح الان
حجم التداول
12,848
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
56,617,987
العنوان: MAIA Biotechnology
القطاع: Healthcare
الصناعة: Biotechnology
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.